0 Комментарии
0 Поделились
715 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Offers
-
Jobs
-
Courses
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Congenital Heart Disease Market Future Scope: Growth, Share, Value, Size, and AnalysisThe conformal coatings market is expected to witness market growth at a rate of 4.5% in the forecast period of 2022 to 2029. The global business landscape is undergoing a transformation, with industries increasingly leaning on deep research and actionable insights to make strategic decisions. One segment seeing tremendous traction is the Conformal Coatings Market, which has proven...0 Комментарии 0 Поделились 813 Просмотры 0 предпросмотр
-
Cyanotic Heart Disease Market Share and Growth Forecast Across Major RegionsComprehensive Outlook on Executive Summary Cyanotic Heart Disease Market Size and Share CAGR Value Data Bridge Market Research analyses a growth rate in the global cyanotic heart disease market in the forecast period 2022-2029. The expected CAGR of global cyanotic heart disease market is tend to be around 9% in the mentioned forecast period. Cyanotic Heart Disease Market...0 Комментарии 0 Поделились 581 Просмотры 0 предпросмотр
-
How Are Insertable Cardiac Monitors Transforming Heart Disease Detection?Executive Summary Insertable Cardiac Monitors (ICM) Market: Growth Trends and Share Breakdown CAGR Value The global insertable cardiac monitors (ICM) market size was valued at USD 910.40 Million in 2025 and is expected to reach USD 3710.58 Million by 2033, at a CAGR of 19.20% during the forecast period This Insertable Cardiac Monitors (ICM) Market...0 Комментарии 0 Поделились 251 Просмотры 0 предпросмотр
-
Anti-Cancer Drug Market Companies: Growth, Share, Value, Size, and Insights"Executive Summary Anti-Cancer Drug Market: Share, Size & Strategic Insights Data Bridge Market Research analyses that the global anti-cancer drug market which was USD 1,20,000.00 million in 2022, would rocket up to USD 2,97,000.00 million by 2030, and is expected to undergo a CAGR of 12.0% during the forecast period. The Anti-Cancer Drug report provides CAGR values along with its...0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр
-
Are Innovative Heart Failure Drugs Changing the Outlook for Cardiovascular Care?Executive Summary Heart Failure Drugs Market Size and Share Forecast CAGR Value Data Bridge Market Research analyses that the heart failure drugs market which was USD 8,010.62 million in 2023, would rocket up to USD 24,919.55 million by 2030, and is expected to undergo a CAGR of 15.56% during the forecast period. This Heart Failure Drugs Market Research Report also conducts analysis...0 Комментарии 0 Поделились 393 Просмотры 0 предпросмотр
-
Epigenetics Market Graph: Growth, Share, Value, Insights, and Trends1. Introduction The Global Epigenetics Market has emerged as one of the most rapidly evolving sectors within the life sciences and biotechnology landscape. Epigenetics, the study of heritable changes in gene expression without alterations in the DNA sequence, is reshaping how researchers understand disease mechanisms, cellular functions, and the intricate regulation of human biology....0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр
-
How Is the Atrial Fibrillation Market Evolving with New Treatments?Key Drivers Impacting Executive Summary Atrial Fibrillation Market Size and Share CAGR Value Global atrial fibrillation market size was valued at USD 2.87 billion in 2024 and is projected to reach USD 7.10 billion by 2032, with a CAGR of 12.0% during the forecast period of 2025 to 2032. This global Atrial Fibrillation Market research report carries out the methodical and...0 Комментарии 0 Поделились 86 Просмотры 0 предпросмотр
-
Key Insights into the U.S. Statin Market Growth and DemandExecutive Summary U.S. Statin Market Size and Share: Global Industry Snapshot CAGR Value The U.S. statin market size was valued at USD 4.59 billion in 2024 and is expected to reach USD 1.57 billion by 2032, at a CAGR of 1.50% during the forecast period Each of the topics covered in the U.S. Statin report is studied very well to get a clear idea about all the factors that are...0 Комментарии 0 Поделились 262 Просмотры 0 предпросмотр